Telmisartan increases fatty acid oxidation in skeletal muscle through a peroxisome proliferator-activated receptor-γ dependent pathway

Journal of Hypertension

Volumn 26, Issue 6, 2008, Pages 1209-1215

  Sugimoto, Ken ^a,b   Kazdová, Ludmila ^c   Qi, Nathan R ^d   Hyakukoku, Masaya ^e   Křen, Vladimír ^f,g   Šimáková, Miroslava ^g   Zídek, Václav ^g   Kurtz, Theodore W ^a   Pravenec, Michal ^f,g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e SAPPORO MEDICAL UNIVERSITY   (Japan)

^f CHARLES UNIVERSITY   (Czech Republic)

^g INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Fatty acid oxidation; Muscle; Peroxisome proliferator activated receptor ; Polydactylous rat; Telmisartan

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; FATTY ACID; LOSARTAN; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SUCROSE; TELMISARTAN; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG MEGADOSE; ENERGY EXPENDITURE; FATTY ACID OXIDATION; GLUCOSE TOLERANCE; INCUBATION TIME; INTRAABDOMINAL FAT; LIPID DIET; MALE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; POLYDACTYLY; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; SOLEUS MUSCLE;

EID: 43449087025     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3282f9b58a     Document Type: Article

References (18)